Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2466-2470

  Naderer, Odin ^a   Nafziger, Anne N ^a,b   Bertino Jr , Joseph S ^a,b  

^a BASSETT HEALTHCARE   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; TRIMETHOPRIM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLIC ACID BLOOD LEVEL; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NEPHROTOXICITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

EID: 0030665046     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2466     Document Type: Article

References (20)

1. Alappan, R., M. A. Perazella, and G. K. Buller. 1996. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann. Intern. Med. 124:316-320.
2. Berg, K. J., A. Gjellestad, G. Norby, K. Rootwelt, O. Djoseland, P. Fauchald, A. Mehl, J. Narverud, and T. Talseth. 1989. Renal effects of trimethoprim in cyclosporin and azathioprine-treated kidney-allografted patients. Nephron 53:218-222.
3. Berglund, F., J. Killander, and R. Pompeius. 1975. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J. Urol. 114: 802-808.
4. Caterson, R. J., P. V. Collett, V. L. Hood, G. G. Duggin, J. S. Horvath, J. R. Johnson, J. Sampson, and D. J. Tiller. 1978. Trimethoprim/sulfamethoxazole and renal function in transplant patients. Clin. Pharmacol. Ther. 23: 553-557.
5. Dean, A. G., J. A. Dean, A. H. Burton, and R. C. Dicker. 1990. EPI Info, version 5: a word processing, database, and statistics program for epidemiology an microcomputers, p. 134-135 and 252-253. USD, Inc., Stone Mountain, Ga.
6. Devine, B. J. 1974. Gentamicin pharmacokinetics. Drug Intell. Clin. Pharm. 8:650-655.
7. Hughes, W., G. Leoung, F. Kramer, S. A. Bozzette, S. Safrin, et al. 1993. Comparison of atovaquone (566c80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328:1521-1527.
8. Hughes, W. T., S. W. Lafon, J. D. Scott, and H. Masur. 1995. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Intect. Dis. 171:1295-1301.
9. Kalowski, S., R. S. Nanra, T. H. Mathew, and P. Kincaid-Smith. 1973. Deterioration in renal function in association with co-trimoxazole therapy. Lancet i:394-397.
10. Kastrup, J., P. Petersen, R. Bartram, and J. M. Hansen. 1985. The effect of trimethoprim on serum creatinine. Br. J. Urol. 57:265-268.
11. Kastrup, J., R. Bartram, P. Petersen, and J. M. Hansen. 1983. Trimetoprims indvirkning pa serum-digoksin og serum-kreatinin. Ugeskr. Laeg. 145:2286-2288. (In Danish.)
12. Leoung, G. S., J. Mills, P. C. Hopewell, W. Hughes, and C. Wofsy. 1986. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:45-48.
13. Medina, I., J. Mills, G. Leoung, P. C. Hopewell, B. Lee, G. Modin, N. Benowitz, and C. B. Wofsy. 1990. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N. Engl. J. Med. 323:776-782.
14. Myre, S. A., J. McCann, M. R. First, and R. J. Cluxton, Jr. 1987. Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers. Ther. Drug Monit. 9:161-165.
15. Roy M. T., M. R. First, S. A. Myre, and W. Cacini. 1982. Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects. Ther. Drug Monit. 4:77-79.
16. Sandberg, T., and B. Trollfors. 1986. Effect of trimethoprim on scrum creatinine in patients with acute cystitis. J. Antimicrob. Chemother. 17:123-124.
17. SAS Institute. 1989. SAS/STAT user's guide, version 6.07, 4th ed. SAS Institute Inc., Cary, N.C.
18. Shouval, D., M. Ligumsky, and D. Ben-Ishay. 1978. Effect of co-trimoxazole on normal creatinine clearance. Lancet i:244-245.
19. Stevens, R. C., S. C. Laizure, C. L. Williams, and D. S. Stein. 1991. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/ kg/day sulfamethoxazole in healthy adult subjects. Antimicrob. Agents Chemother. 35:1884-1890.
20. Stevens, R. C., S. C. Laizure, P. L. Sanders, and D. S. Stein. 1993. Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers. Antimicrob. Agents Chemother. 37:448-452.